193 related articles for article (PubMed ID: 20172969)
1. Transforming growth factor-{beta} (TGF{beta}) receptors I/II differentially regulate TGF{beta}1 and IGF-binding protein-3 mitogenic effects in the human placenta.
Forbes K; Souquet B; Garside R; Aplin JD; Westwood M
Endocrinology; 2010 Apr; 151(4):1723-31. PubMed ID: 20172969
[TBL] [Abstract][Full Text] [Related]
2. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
Schedlich LJ; Yenson VM; Baxter RC
Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
[TBL] [Abstract][Full Text] [Related]
3. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells.
Kuemmerle JF; Murthy KS; Bowers JG
Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G795-802. PubMed ID: 15178549
[TBL] [Abstract][Full Text] [Related]
4. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
Han VK; Bassett N; Walton J; Challis JR
J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
[TBL] [Abstract][Full Text] [Related]
5. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.
Rosendahl AH; Forsberg G
Kidney Int; 2006 Nov; 70(9):1584-90. PubMed ID: 16969385
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta.
Forbes K; Westwood M; Baker PN; Aplin JD
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1313-22. PubMed ID: 18400990
[TBL] [Abstract][Full Text] [Related]
7. Developmentally regulated expression of IGF binding protein-3 (IGFBP-3) in human placental fibroblasts: effect of exogenous IGFBP-3 on IGF-1 action.
Rogers J; Wiltrout L; Nanu L; Fant ME
Regul Pept; 1996 Mar; 61(3):189-95. PubMed ID: 8701035
[TBL] [Abstract][Full Text] [Related]
8. IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells.
Crosley EJ; Dunk CE; Beristain AG; Christians JK
Reprod Biol Endocrinol; 2014 Dec; 12():123. PubMed ID: 25475528
[TBL] [Abstract][Full Text] [Related]
9. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals.
Han VK; Carter AM
Placenta; 2000 May; 21(4):289-305. PubMed ID: 10833363
[TBL] [Abstract][Full Text] [Related]
10. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
11. TbetaRI/Alk5-independent TbetaRII signaling to ERK1/2 in human skin cells according to distinct levels of TbetaRII expression.
Bandyopadhyay B; Han A; Dai J; Fan J; Li Y; Chen M; Woodley DT; Li W
J Cell Sci; 2011 Jan; 124(Pt 1):19-24. PubMed ID: 21172820
[TBL] [Abstract][Full Text] [Related]
12. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
Fanayan S; Firth SM; Butt AJ; Baxter RC
J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
[TBL] [Abstract][Full Text] [Related]
14. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway.
Rousse S; Lallemand F; Montarras D; Pinset C; Mazars A; Prunier C; Atfi A; Dubois C
J Biol Chem; 2001 Dec; 276(50):46961-7. PubMed ID: 11598109
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 mediate TGF-beta- and myostatin-induced suppression of proliferation in porcine embryonic myogenic cell cultures.
Kamanga-Sollo E; Pampusch MS; White ME; Hathaway MR; Dayton WR
Exp Cell Res; 2005 Nov; 311(1):167-76. PubMed ID: 16214131
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
18. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
19. Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects.
Schmid C; Ghirlanda-Keller C; Zapf J
Eur J Endocrinol; 2001 Aug; 145(2):213-21. PubMed ID: 11454519
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways.
Kiepe D; Ciarmatori S; Hoeflich A; Wolf E; Tönshoff B
Endocrinology; 2005 Jul; 146(7):3096-104. PubMed ID: 15845624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
